The effect of dapagliflozin on apolipoprotein B and glucose fluxes in patients with type 2 diabetes and well‐controlled plasma LDL cholesterol

AIM: To dissect the effects of the sodium‐glucose linked transporter 2 inhibitor dapagliflozin on lipid metabolism and assess whether these effects could potentially offset cardiovascular benefit with this drug‐class. MATERIALS AND METHODS: We assessed the effect of dapagliflozin on lipid metabolism...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouter, Kristien E. C., van Bommel, Erik J. M., Jansen, Hans, van Harskamp, Dewi, Schierbeek, Henk, Ackermans, Mariëtte T., Serlie, Mireille J., Schimmel, Alinda W. M., Nieuwdorp, Max, Dallinga‐Thie, Geesje M., van Raalte, Daniël H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318266/
https://www.ncbi.nlm.nih.gov/pubmed/32026592
http://dx.doi.org/10.1111/dom.13990

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318266/
https://www.ncbi.nlm.nih.gov/pubmed/32026592
http://dx.doi.org/10.1111/dom.13990

Ejemplares similares